TELCON RF PHARMACEUTICAL. Inc. (200230) Price & Analysis

― Followers

200230 Stock Chart & Stats

₩2250.00

-₩10.00(-0.44%)

Aug 28, 2026

―

Day’s Range― - ―

52-Week Range₩1,700.00 - ₩23,850.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)77.77K

Market Cap

₩21.43B

Enterprise Value₩66.38K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.08

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-1948.83

Shares Outstanding9,482,269

10 Day Avg. Volume92,021

30 Day Avg. Volume77,766

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

200230 FAQ

What was TELCON RF PHARMACEUTICAL. Inc.’s price range in the past 12 months?

TELCON RF PHARMACEUTICAL. Inc. lowest stock price was ₩1700.00 and its highest was ₩23850.00 in the past 12 months.

What is TELCON RF PHARMACEUTICAL. Inc.’s market cap?

TELCON RF PHARMACEUTICAL. Inc.’s market cap is ₩21.43B.

When is TELCON RF PHARMACEUTICAL. Inc.’s upcoming earnings report date?

TELCON RF PHARMACEUTICAL. Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 75 days.

How were TELCON RF PHARMACEUTICAL. Inc.’s earnings last quarter?

TELCON RF PHARMACEUTICAL. Inc. released its earnings results on Aug 14, 2026. The company reported -₩1948.827 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is TELCON RF PHARMACEUTICAL. Inc. overvalued?

According to Wall Street analysts TELCON RF PHARMACEUTICAL. Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does TELCON RF PHARMACEUTICAL. Inc. pay dividends?

TELCON RF PHARMACEUTICAL. Inc. does not currently pay dividends.

What is TELCON RF PHARMACEUTICAL. Inc.’s EPS estimate?

TELCON RF PHARMACEUTICAL. Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TELCON RF PHARMACEUTICAL. Inc. have?

TELCON RF PHARMACEUTICAL. Inc. has 9,482,269 shares outstanding.

What happened to TELCON RF PHARMACEUTICAL. Inc.’s price movement after its last earnings report?

TELCON RF PHARMACEUTICAL. Inc. reported an EPS of -₩1948.827 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.499%.

Which hedge fund is a major shareholder of TELCON RF PHARMACEUTICAL. Inc.?

Currently, no hedge funds are holding shares in KR:200230

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology